Public health strategies urged to combat early-onset type 2 diabetes in China

A new study led by researchers from Peking University, published in Health Data Science, reveals a sharp rise in the burden of early-onset type 2 diabetes (T2D) among adolescents and young adults in China from 1990 to 2021.

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint

Pfizer is planning to leave the Biotechnology Innovation Organization, a source familiar with the matter confirmed to Endpoints News, as it will not renew its

December 7, 2023

Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS – Psychedelic Alpha

VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher

June 15, 2023

AltruBio secures $225M for an updated version of its ulcerative colitis drug

Bay Area and Taipei biotech AltruBio has raised $225 million in a Series B to move forward its experimental drug for ulcerative colitis and other

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.